|
WO1999009155A1
(en)
|
1997-08-19 |
1999-02-25 |
Human Genome Sciences, Inc. |
70 human secreted proteins
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
JP4357738B2
(ja)
|
1997-09-12 |
2009-11-04 |
アポテック エール エ デ− エス．アー． |
システインリッチなレセプターであるｔｒａｉｎ
|
|
AU9482498A
(en)
*
|
1997-09-17 |
1999-04-05 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
|
US6849719B2
(en)
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
|
US20030039648A1
(en)
|
1998-09-16 |
2003-02-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
NZ508878A
(en)
|
1998-05-15 |
2003-08-29 |
Genentech Inc |
IL-17B and IL-17Cactive variants of IL-17 which stimulates epithelial, endothelial and fibroblastic cells
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US6291663B1
(en)
*
|
1999-03-03 |
2001-09-18 |
Board Of Trustees Of The University Of Arkansas |
TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
|
|
US7109292B2
(en)
|
1999-03-08 |
2006-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US8133734B2
(en)
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
|
JP2002543838A
(ja)
*
|
1999-05-13 |
2002-12-24 |
メディカル リサーチ カウンシル |
Ｏｘ２レセプターホモログ
|
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1623992A3
(en)
*
|
1999-09-01 |
2006-05-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
JP2003514524A
(ja)
|
1999-11-18 |
2003-04-22 |
コルバス・インターナショナル・インコーポレイテッド |
エントセリアーゼをコードしている核酸、エンドセリアーゼおよびその使用
|
|
EP1897945B1
(en)
*
|
1999-12-23 |
2012-01-18 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
US20020155499A1
(en)
*
|
2000-09-25 |
2002-10-24 |
Leiby Kevin R. |
32624, a novel human UDP-glucuronosyl and glycosyl transferase family member and uses thereof
|
|
US20020164745A1
(en)
*
|
2000-06-15 |
2002-11-07 |
Meyers Rachel A. |
53320, a novel human acyltransferase and uses therefor
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
EP1280923A2
(en)
|
2000-04-28 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
14094, a human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6965018B2
(en)
|
2000-06-06 |
2005-11-15 |
Bristol-Myers Squibb Company |
Antibodies directed to B7-related polypeptide, BSL-2
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
JP2004500872A
(ja)
*
|
2000-06-22 |
2004-01-15 |
バイオジェン インコーポレイテッド |
Ｇｐ３５４核酸およびポリペプチド
|
|
US20020061574A1
(en)
*
|
2000-09-01 |
2002-05-23 |
Rachel Meyers |
16658, 14223, and 16002, novel human kinases and uses therefor
|
|
AU2001273194A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Amgen Inc. |
B7-Like Molecules and Uses Thereof
|
|
WO2002010217A2
(en)
|
2000-08-02 |
2002-02-07 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
|
CA2420392A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
|
EP1334179A2
(en)
|
2000-11-14 |
2003-08-13 |
Bristol-Myers Squibb Company |
A human serpin secreted from lymphoid cells lsi-01
|
|
DE10106835A1
(de)
*
|
2001-02-14 |
2002-09-05 |
Basf Lynx Bioscience Ag |
Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen
|
|
WO2002064769A1
(en)
*
|
2001-02-15 |
2002-08-22 |
Shionogi & Co., Ltd. |
Novel disease marker
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
AU2002257088A1
(en)
*
|
2001-03-12 |
2002-09-24 |
Incyte Genomics, Inc. |
Immunoglobulin superfamily proteins
|
|
WO2002072786A2
(en)
|
2001-03-13 |
2002-09-19 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
CA2441378A1
(en)
|
2001-03-22 |
2002-10-03 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
|
|
US7105333B2
(en)
|
2001-03-27 |
2006-09-12 |
Deadreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
|
|
US7033790B2
(en)
|
2001-04-03 |
2006-04-25 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2002083856A2
(en)
|
2001-04-11 |
2002-10-24 |
Bristol-Myers Squibb Company |
Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
|
|
JP2005506832A
(ja)
|
2001-05-14 |
2005-03-10 |
デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー |
トランスメンブランセリンプロテアーゼ１０をコードする核酸分子、コードされるポリペプチドおよびそれに基づく方法
|
|
WO2002101075A2
(en)
|
2001-06-13 |
2002-12-19 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
WO2003000021A2
(en)
*
|
2001-06-22 |
2003-01-03 |
Biogen, Inc. |
Pancam nucleic acids and polypeptides
|
|
WO2003004530A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human somatostatin receptor-like protein
|
|
IL159872A0
(en)
*
|
2001-07-26 |
2004-06-20 |
Genset Sa |
Gmg-2 polypeptides and their use
|
|
JP4702819B2
(ja)
|
2001-08-01 |
2011-06-15 |
生化学工業株式会社 |
コンドロイチン合成酵素
|
|
JP4102898B2
(ja)
*
|
2001-08-23 |
2008-06-18 |
独立行政法人科学技術振興機構 |
造血幹細胞増殖調節因子及びそれをコードするポリヌクレオチド
|
|
WO2003099318A2
(en)
|
2002-05-29 |
2003-12-04 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
|
KR101008758B1
(ko)
|
2001-09-18 |
2011-01-14 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
|
WO2003025162A2
(en)
*
|
2001-09-20 |
2003-03-27 |
Bayer Healthcare Ag |
Regulation of human prolyl 4-hydroxylase alpha subunit precursor
|
|
JP2005508171A
(ja)
*
|
2001-11-02 |
2005-03-31 |
タノックス インコーポレーテッド |
Ｂ細胞悪性病変の診断及び予防に用いるためのｂ細胞リンパ腫特異抗原
|
|
US7396662B2
(en)
|
2001-12-19 |
2008-07-08 |
Immunex Corporation |
C-type lectin polypeptides
|
|
DE10211088A1
(de)
*
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
AU2002254651A1
(en)
*
|
2002-04-17 |
2003-11-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US7232676B2
(en)
*
|
2002-05-31 |
2007-06-19 |
Seikagaku Kogyo Kabushiki Kaisha |
Chondroitin synthase and nucleic acid encoding the enzyme
|
|
WO2003102182A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Hidetoshi Inoko |
Inflammatory skin disease-related slurp-2 gene and utilization thereof
|
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
DE10242016A1
(de)
*
|
2002-09-11 |
2004-03-25 |
Esplora GmbH c/o TU Darmstadt Institut für Biochemie |
Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon
|
|
EP1575497A4
(en)
*
|
2002-09-11 |
2010-11-03 |
Genentech Inc |
NEW COMPOSITION AND METHOD FOR TREATING PSORIASIS
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
KR20050085881A
(ko)
*
|
2002-12-26 |
2005-08-29 |
다케다 야쿠힌 고교 가부시키가이샤 |
신규 단백질 및 그 용도
|
|
WO2004063226A2
(en)
*
|
2002-12-27 |
2004-07-29 |
Applied Research Systems Ars Holding N.V. |
Novel fibrillin-like polypeptides
|
|
WO2004064740A2
(en)
*
|
2003-01-16 |
2004-08-05 |
University Of Virginia Patent Foundation |
Sperm specific lysozyme-like proteins
|
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
EP1641822B1
(en)
|
2003-07-08 |
2013-05-15 |
Genentech, Inc. |
Il-17 a/f heterologous polypeptides and therapeutic uses thereof
|
|
AU2004266246A1
(en)
|
2003-08-14 |
2005-03-03 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
US7825235B2
(en)
|
2003-08-18 |
2010-11-02 |
Isis Pharmaceuticals, Inc. |
Modulation of diacylglycerol acyltransferase 2 expression
|
|
EP1712619A4
(en)
*
|
2003-12-24 |
2008-01-02 |
Takeda Pharmaceutical |
MEANS FOR PREVENTING / CUREING CANCER
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
CN101010342A
(zh)
|
2004-07-02 |
2007-08-01 |
健泰科生物技术公司 |
用于治疗非何杰金淋巴瘤的组合物和方法
|
|
WO2006017673A2
(en)
|
2004-08-03 |
2006-02-16 |
Biogen Idec Ma Inc. |
Taj in neuronal function
|
|
ES2414460T3
(es)
|
2004-08-04 |
2013-07-19 |
Amgen Inc. |
Anticuerpos para Dkk-1
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
US20110097330A1
(en)
*
|
2005-03-11 |
2011-04-28 |
Genentech, Inc. |
Novel Gene Disruptions, Compostitions and Methods Relating Thereto
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
CA2630483C
(en)
|
2005-12-08 |
2015-05-19 |
Medarex, Inc. |
Human monoclonal antibodies to o8e
|
|
WO2007107774A2
(en)
*
|
2006-03-22 |
2007-09-27 |
Cartela R & D Ab |
Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
|
|
CA2649387A1
(en)
*
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
WO2008019351A2
(en)
|
2006-08-04 |
2008-02-14 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to diacylglycerol acyltransferase 1
|
|
ES2625259T3
(es)
|
2006-08-29 |
2017-07-19 |
Oxford Biotherapeutics Ltd |
Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
|
|
US8058014B2
(en)
|
2006-09-29 |
2011-11-15 |
University Of Maryland, Baltimore |
Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
|
|
KR20170023209A
(ko)
|
2008-05-05 |
2017-03-02 |
노비뮨 에스 에이 |
항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
|
|
JP2011523560A
(ja)
|
2008-06-02 |
2011-08-18 |
ダナ−ファーバー キャンサー インスティテュート インク． |
Ｘｂｐ１ペプチド、ｃｄ１３８ペプチドおよびｃｓ１ペプチド
|
|
BRPI1009232B1
(pt)
|
2009-03-05 |
2022-05-03 |
E.R. Squibb & Sons, Llc. |
Anticorpo monoclonal isolado ou uma porção de ligação de antígeno do mesmo, ou um fragmento de anticorpo, composição que os compreende, molécula de ácido nucleico, hibridoma e métodos para a preparação de um anticorpo anti-cadm1
|
|
PE20120815A1
(es)
|
2009-05-05 |
2012-07-08 |
Novimmune Sa |
Anticuerpos anti il-17f y metodos de uso de los mismos
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
CN105377288B
(zh)
|
2012-11-05 |
2019-11-15 |
达纳-法伯癌症研究所股份有限公司 |
Xbp1、cd138和cs1肽的组合物制备药物的用途
|
|
UA128182C2
(uk)
|
2012-11-13 |
2024-05-01 |
Біонтех Аґ |
Агенти для лікування експресуючих клаудин ракових захворювань
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
PE20180800A1
(es)
|
2015-07-10 |
2018-05-09 |
Ionis Pharmaceuticals Inc |
Moduladores de diaciglicerol aciltransferasa 2 (dgat2)
|